NSN 6505-01-073-1552 · NIIN 010731552 · FSC 6505
NO DASHES 6505010731552
In Stock
THEOPHYLLINE EXTENDED-RELEASE TA
Drugs and Biologicals
Technical characteristics
6 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT 300.000 |
| CBBL | FEATURES PROVIDED | UNIT DOSE |
| CQCT | PRIMARY CONTAINER TYPE | STRIP |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | TABLETS 100.000 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG I.S. 100S PG |
| THPE | THERAPEUTIC EQUIVALENT | THEO-DUR BY KEY PHARM |
Cross-references
12 manufacturer part numbers on file for this NSN — each shown against the CAGE code it belongs to.
| Manufacturer part number | CAGE |
|---|---|
| THEO-DUR | 1F095 |
| NDC00085-0584-81 | 1F095 |
| THEO-DUR | 24214 |
| NDC00369-0803-81 | 24214 |
| NDC50111-0459-01 | 3PYX2 |
| NDC00677-0817-01 | 59225 |
| NDC00456-4330-01 | 65050 |
| NDC00258-3581-01 | 6X308 |
| NDC61570-0019-01 | 09GL2 |
| NDC00904-1612-61 | 0SYT3 |
| NDC00182-1400-89 | 0LXM4 |
| NDC00603-5946-21 | 0ET99 |
Supersedes
This item replaces cancelled NIIN 011534298. An older drawing citing one of those numbers resolves here.